BRUKER CORPORATION Other Comprehensive Income (Loss), before Reclassifications, Net of Tax
BRUKER CORPORATION (BRKR) reported Other Comprehensive Income (Loss), before Reclassifications, Net of Tax of $98.10 million for the 12-month period ending 2017-12-31, per its 10-K filed 2018-03-16.
Discontinued › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax · last filed 2018-03-16
- BRUKER CORPORATION other comprehensive income (loss), before reclassifications, net of tax for the quarter ending 2016-03-31 was $33.40M.
- BRUKER CORPORATION other comprehensive income (loss), before reclassifications, net of tax for the quarter ending 2015-12-31 was -$39.30M.
- BRUKER CORPORATION other comprehensive income (loss), before reclassifications, net of tax for the quarter ending 2015-09-30 was -$9.00M.
- BRUKER CORPORATION other comprehensive income (loss), before reclassifications, net of tax for the quarter ending 2015-06-30 was $34.60M.
- BRUKER CORPORATION other comprehensive income (loss), before reclassifications, net of tax for fiscal 2017 was $98.10M.
- BRUKER CORPORATION other comprehensive income (loss), before reclassifications, net of tax for fiscal 2016 was -$35.70M.
- BRUKER CORPORATION other comprehensive income (loss), before reclassifications, net of tax for fiscal 2015 was -$86.40M.
- BRUKER CORPORATION other comprehensive income (loss), before reclassifications, net of tax for fiscal 2014 was -$154.30M, a 464.78% decline from fiscal 2013.
| Period end | Other Comprehensive Income (Loss), before Reclassifications, Net of Tax 3 month | Other Comprehensive Income (Loss), before Reclassifications, Net of Tax 6 month | Other Comprehensive Income (Loss), before Reclassifications, Net of Tax 9 month | Other Comprehensive Income (Loss), before Reclassifications, Net of Tax 12 month |
|---|---|---|---|---|
| 2017-12-31 | $98.10M 10-K · filed 2018-03-16 | |||
| 2016-12-31 | -$35.70M 10-K · filed 2018-03-16 | |||
| 2016-03-31 | $33.40M 10-Q · filed 2016-05-06 | -$5.90M derived: sum of 2 quarters · filed 2018-03-16 | -$14.90M derived: sum of 3 quarters · filed 2018-03-16 | $19.70M derived: sum of 4 quarters · filed 2018-03-16 |
| 2015-12-31 | -$39.30M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-16 | -$48.30M derived: sum of 2 quarters · filed 2018-03-16 | -$13.70M derived: sum of 3 quarters · filed 2018-03-16 | -$86.40M 10-K · filed 2018-03-16 |
| 2015-09-30 | -$9.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-06 | $25.60M derived: sum of 2 quarters · filed 2015-11-06 | -$47.10M 10-Q · filed 2015-11-06 | -$117.70M derived: sum of 4 quarters · filed 2017-03-01 |
| 2015-06-30 | $34.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-07 | -$38.10M 10-Q · filed 2015-08-07 | -$108.70M derived: sum of 3 quarters · filed 2017-03-01 | -$191.70M derived: sum of 4 quarters · filed 2017-03-01 |
| 2015-03-31 | -$72.70M 10-Q · filed 2015-05-08 | -$143.30M derived: sum of 2 quarters · filed 2017-03-01 | -$226.30M derived: sum of 3 quarters · filed 2017-03-01 | |
| 2014-12-31 | -$70.60M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | -$153.60M derived: sum of 2 quarters · filed 2017-03-01 | -$154.30M 10-K · filed 2017-03-01 | |
| 2014-09-30 | -$83.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-07 | -$83.70M 10-Q · filed 2014-11-07 | ||
| 2014-06-30 | -$700.00K 10-Q · filed 2014-08-08 | |||
| 2013-12-31 | $42.30M 10-K · filed 2016-02-29 | |||
| 2012-12-31 | -$7.10M 10-K · filed 2015-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Avantor, Inc. (AVTR) | United States | $10.501B | -9.72 |
| REVVITY, INC. (RVTY) | United States | $16.814B | 53.44 |
| Alamar Biosciences, Inc. (ALMR) | United States | $2.300B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |